XSNX

NovAccess Global Inc. XSNX

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode XSNX CUBT ENZN MLPH RGUS SOEN SPIR XDSL
6M -66.67 % -40.48 % -11.58 % -25.00 % 0.00 % 0.00 % 39.98 % 0.00 %
YTD -92.31 % -44.44 % -55.80 % 200.00 % 0.00 % 900.00 % -11.80 % 0.00 %
1Y -98.00 % -42.31 % -27.65 % 200.00 % 0.00 % 900.00 % 36.10 % -50.00 %
3Y -99.92 % -62.50 % -70.53 % -57.14 % -99.50 % 0.00 % 47.92 % -99.66 %
5Y -99.98 % -50.00 % -53.19 % -91.43 % -99.18 % -99.25 % -83.18 % -99.71 %
10Y -100.00 % 7 400.00 % -90.67 % -94.00 % -99.89 % -95.12 % -83.18 % -100.00 %
From the beginning -100.00 % -100.00 % -94.23 % -97.60 % -100.00 % -99.99 % -83.18 % -100.00 %

Dividend

Enzon Pharmaceuticals, Inc.